Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2006-05-16
2006-05-16
Winkler, Ulrike (Department: 1648)
Chemistry: molecular biology and microbiology
Vector, per se
C424S093200, C424S093600, C435S005000, C435S069100, C435S091400, C435S173300, C435S235100, C435S252300, C514S04400A, C536S023740
Reexamination Certificate
active
07045344
ABSTRACT:
In vitro methods for making a recombinant adenoviral genome, as well as kits for practicing the same and the recombinant adenovirus vectors produced thereby, are provided. In the subject methods, the subject genomes are prepared from first and second vectors. The first vector includes an adenoviral genome having an E region deletion and three different, non-adenoviral restriction endonuclease sites located in the E region. The second vector is a shuttle vector and includes an insertion nucleic acid flanked by two of the three different non-adenoviral endonuclease sites present in the first vector. Cleavage products are prepared from the first and second vectors using the appropriate restriction endonucleases. The resultant cleavage products are then ligated to produce the subject recombinant adenovirus genome. The subject adenoviral genomes find use in a variety of applications, including as vectors for use in a variety of applications, including gene therapy.
REFERENCES:
patent: 5075227 (1991-12-01), Hagen
patent: 5354678 (1994-10-01), Lebkowski et al.
patent: 5585362 (1996-12-01), Wilson et al.
patent: 5589377 (1996-12-01), Lebkowski et al.
patent: 5616326 (1997-04-01), Spibey
patent: 5670488 (1997-09-01), Gregory et al.
patent: 5700470 (1997-12-01), Saito et al.
patent: 5707618 (1998-01-01), Armentano et al.
patent: 5731172 (1998-03-01), Saito et al.
patent: 5747072 (1998-05-01), Davidson et al.
patent: 5756283 (1998-05-01), Wilson et al.
patent: 5789390 (1998-08-01), Descamps et al.
patent: 5820868 (1998-10-01), Mittal et al.
patent: 5837484 (1998-11-01), Trempe et al.
patent: 5843742 (1998-12-01), Natsoulis et al.
patent: 5851806 (1998-12-01), Kovesdi et al.
patent: 5858351 (1999-01-01), Podsakoff et al.
patent: 5869037 (1999-02-01), Crystal et al.
patent: 5871982 (1999-02-01), Wilson et al.
patent: 5877011 (1999-03-01), Armentano et al.
patent: 5880102 (1999-03-01), George et al.
patent: 5885808 (1999-03-01), Spooner et al.
patent: 5891690 (1999-04-01), Massie
patent: 5919676 (1999-07-01), Graham et al.
patent: 5922576 (1999-07-01), He et al.
patent: 5928944 (1999-07-01), Seth et al.
patent: 5932210 (1999-08-01), Gregory et al.
patent: 5952221 (1999-09-01), Kurtzman et al.
patent: 5962311 (1999-10-01), Wickham et al.
patent: 5962313 (1999-10-01), Podsakoff et al.
patent: 6303362 (2001-10-01), Kay et al.
Berkner et al. (1983) “Generation of Adenovirus by Transfection of Plasmids,”Nuc. Acids Res.,vol. 11(17):6003-6021.
Bett et al. (1994) “An Efficient and Flexible System for Construction of Adenovirus Vectors with Insertions of Deletions in Early Regions 1 and 3,”Proc. Natl. Acad. Sci. USA,vol. 91:8802-8806.
Chartier et al. (1996) “Efficient Generation of Recombinant Adenovirus Vectors by Homologous Recombination inEscherichia coli,” Journal of Virology,vol. 70(7):4805-4810.
Conley et al. Recombination-dependent recirularization of linerized pBR322 plasmid DNA following transformation ofE. coli.Molecular General Genetics. vol. 194 (1984) pp. 211-218.
Crouzet et al. (1997) “Recombinational Construction inEscherichia coliof Infectious Adenoviral Genomes,”Proc Natl. Acad. Sci. USA,vol. 94:1414-1419.
Gilardi et al. (1990) “Expression of Human α1-antitrypsin Using a Recombinant Adenovirus Vector,”FEBS Letters,vol. 267(1):60-62.
Gorziglia et al. J. Virology (Jun. 1996) 70:4173-4178.
He et al. (1998) “A Simplified System for Generating Recombinant Adenoviruses,”Proc. Natl. Acad. Sci. USA,vol. 95:2509-2514.
Ketner et al. (1994) “Efficient Manipulation of the Human Adenovirus Genome as an Infectious Yeast Artificial Chromosome Clone,”Proc. Natl. Acad. Sci. USA,vol. 91:6186-6190.
Fisher et al. Virology (1996) 217:11-22.
Majumder et al. “Recombinant enrichment by exploitation of restriction sites with interupted palindromes:design, synthesis and incorporation of zero background linkers in cloning and expression vectors,”Gene,vol. 151 (1994) pp. 147-151.
Majumder et al. “Background-minimized cassette mutagenisis by PCR using cassette-specific selection markers.”PCR Methods and Applications,vol. 4, No. 4 (1995) pp. 212-218.
Miyake et al. (1996) “Efficient Generation of Recombinant Adenoviruses Using Adenovirus DNA-Terminal Protein Complex and a Cosmid Bearing the Full-Length Virus Genome,”Proc. Natl. Acad. Sci. USA,vol. 93:1320-1324.
Rosenfeld et al. (1991) “Adenovirus-Mediated Transfer of a Recombinant α1-Antitrypsin Gene to the Lung Epithelium in Vivo,”Science,vol. 252:431-434.
Sambrook et al. Molecular cloning, a laboratory manual. Cold Spring Harbor Laboratory Press, 1989.
Trapnell et al. Curr. Opin. Biol. (1994) 5:617-625.
Kay Mark A.
Mizuguchi Hiroyuki
Bozicevic Field & Francis LLP
Field Bret E.
The Board of Trustees of the LeLand Stanford Junior University
The University of Washington
Winkler Ulrike
LandOfFree
Adenoviral vector and methods for making and using the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenoviral vector and methods for making and using the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenoviral vector and methods for making and using the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3591217